Determinants of the Cancer Drug Funding Process in Canada
Background: Canada has a publicly funded healthcare system with a complex drug funding process. After Health Canada approval to market a drug, the pan-Canadian Oncology Drug Review (pCODR) (now renamed the CADTH reimbursement review) makes a non-binding funding recommendation to the Canadian provinc...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2022-03-01
|
| 叢編: | Current Oncology |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/1718-7729/29/3/162 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|